Akari Therapeutics PLC (AKTX) financials · $17.2M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Akari Therapeutics PLC (AKTX) $17.2M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$17.3M | -$21.6M |
| Net Income | -$17.3M | -$19.8M |
| EPS (Diluted) | N/A | N/A |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $47.9M | $50.6M |
| Current Assets | $5.46M | $2.95M |
| Cash & Equivalents | N/A | $2.60M |
| Total Liabilities | $19.6M | $28.3M |
| Current Liabilities | $12.4M | $19.9M |
| Shareholders' Equity | $28.3M | $22.2M |
| Retained Earnings | -$264.6M | -$247.3M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$10.6M | -$12.6M |
| Investing Cash Flow | N/A | $382.0K |
| Financing Cash Flow | $13.2M | $11.0M |
| Net Change in Cash | $2.60M | N/A |
FAQ
What is AKTX P/E and revenue?
Akari Therapeutics PLC (AKTX) $17.2M cap.
What is AKTX revenue?
AKTX income-statement cache has no revenue figure yet.
Is AKTX profitable?
Akari Therapeutics PLC last cached net income is -$17.3M (FY2025).
What are AKTX total assets?
Akari Therapeutics PLC last cached total assets are $47.9M (FY2025).
What is AKTX free cash flow?
No cached cash-flow row for AKTX yet.
Not investment advice. Cached statements, not a live tape.